SHh-Gli1 signaling pathway promotes cell survival by mediating baculoviral IAP repeat-containing 3 (BIRC3) gene in pancreatic cancer cells

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Huizhong GanJianming Xu

Abstract

The abnormally activated hedgehog (Hh) signaling pathway is involved in the regulation of proliferation and apoptosis in pancreatic cancer cells, while its exact molecular mechanism is not clear. The purpose of this study was to investigate the regulatory effect of Hh signaling pathway on the transcription of BIRC3 gene and its underlying mechanism in pancreatic cancer cells, as well as the relationship between the Gli1-dependent BIRC3 transcription and cell survival. Firstly, we examined the effect of knockdown or overexpression of Hh on BIRC3 messenger RNA (mRNA) expression by real-time RT-PCR. Then, the regulatory mechanism of Gli1 to BIRC3 gene transcription was investigated by XChIP-PCR and luciferase assays. Finally, the cell survival mediated by the Gli1-dependent BIRC3 transcription was studied by MTT and annexin V-FITC/propidiumiodide (PI) assays. We found that the expression level of BIRC3 mRNA was positively correlated to SHh/Gli1 signaling activation in three pancreatic cancer cell lines. The XChIP-PCR and luciferase assays data showed that the transcription factor Gli1 bound to some enhancers within the promoter regions of BIRC3 gene and promoted gene transcription. The cell proliferation was increased significantl...Continue Reading

References

Aug 15, 2003·Development·Hiroshi KawahiraMatthias Hebrok
Jul 23, 2005·Neoplasia : an International Journal for Oncology Research·Murali D BashyamJonathan R Pollack
Feb 9, 2006·Cellular and Molecular Life Sciences : CMLS·J LauM Hebrok
Jul 16, 2008·Gastroenterology·David A Cano, Matthias Hebrok
May 19, 2010·Proceedings of the National Academy of Sciences of the United States of America·Sara CervantesMatthias Hebrok
May 31, 2011·Lancet·Audrey VincentMichael Goggins
Jun 25, 2013·Chemical Biology & Drug Design·Mohammad SaleemBashir Ahmad
Jul 17, 2013·CA: a Cancer Journal for Clinicians·Christopher L WolfgangRalph H Hruban
Oct 26, 2013·Mechanisms of Development·Nagaharu TsukijiToshihiko Shiroishi
May 2, 2014·World Journal of Gastroenterology : WJG·Luo-Wei WangZhao-Shen Li
Jun 21, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Changhwan YoonSam S Yoon
Oct 4, 2014·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Edward J KimDiane M Simeone
Oct 15, 2014·Cell Reports·Esha MathewMarina Pasca di Magliano
Dec 17, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jianjun LeiXuqi Li
Mar 3, 2015·Seminars in Oncology·Geoffrey KozakJonathan R Brody
May 16, 2015·Biochimica Et Biophysica Acta·Divya SinghSharmila Shankar
May 20, 2015·Expert Opinion on Therapeutic Patents·Alexander W HirdBin Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis